Your browser doesn't support javascript.
loading
Antitumor Activity of the Novel BTK Inhibitor TG-1701 Is Associated with Disruption of Ikaros Signaling in Patients with B-cell Non-Hodgkin Lymphoma.
Ribeiro, Marcelo Lima; Reyes-Garau, Diana; Vinyoles, Meritxell; Profitós Pelejà, Núria; Santos, Juliana Carvalho; Armengol, Marc; Fernández-Serrano, Miranda; Sedó Mor, Alícia; Bech-Serra, Joan J; Blecua, Pedro; Musulen, Eva; De La Torre, Carolina; Miskin, Hari; Esteller, Manel; Bosch, Francesc; Menéndez, Pablo; Normant, Emmanuel; Roué, Gaël.
Afiliação
  • Ribeiro ML; Lymphoma Translational Group, Josep Carreras Leukaemia Research Institute, Badalona, Spain.
  • Reyes-Garau D; Laboratory of Immunopharmacology and Molecular Biology, Sao Francisco University Medical School, Braganca Paulista, São Paulo, Brazil.
  • Vinyoles M; Lymphoma Translational Group, Josep Carreras Leukaemia Research Institute, Badalona, Spain.
  • Profitós Pelejà N; Stem Cell Biology, Developmental Leukemia and Immunotherapy Group, Josep Carreras Leukaemia Research Institute, Badalona, Spain.
  • Santos JC; Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.
  • Armengol M; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Barcelona, Spain.
  • Fernández-Serrano M; Lymphoma Translational Group, Josep Carreras Leukaemia Research Institute, Badalona, Spain.
  • Sedó Mor A; Lymphoma Translational Group, Josep Carreras Leukaemia Research Institute, Badalona, Spain.
  • Bech-Serra JJ; Lymphoma Translational Group, Josep Carreras Leukaemia Research Institute, Badalona, Spain.
  • Blecua P; Autonomous University of Barcelona, Barcelona, Spain.
  • Musulen E; Lymphoma Translational Group, Josep Carreras Leukaemia Research Institute, Badalona, Spain.
  • De La Torre C; Autonomous University of Barcelona, Barcelona, Spain.
  • Miskin H; Lymphoma Translational Group, Josep Carreras Leukaemia Research Institute, Badalona, Spain.
  • Esteller M; Autonomous University of Barcelona, Barcelona, Spain.
  • Bosch F; Proteomics Unit, Josep Carreras Leukaemia Research Institute, Badalona, Spain.
  • Menéndez P; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute, Badalona, Spain.
  • Normant E; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute, Badalona, Spain.
  • Roué G; Department of Pathology, Hospital Universitari General de Catalunya-Grupo Quironsalud, Sant Cugat del Vallès, Spain.
Clin Cancer Res ; 27(23): 6591-6601, 2021 12 01.
Article em En | MEDLINE | ID: mdl-34551904
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma não Hodgkin / Leucemia Linfocítica Crônica de Células B Tipo de estudo: Risk_factors_studies / Screening_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma não Hodgkin / Leucemia Linfocítica Crônica de Células B Tipo de estudo: Risk_factors_studies / Screening_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article